Tags |
|
|
Links |
|
|
Top Adding - Foreclosure Investing Money Can Come From Anywhere
As a foreclosure investor, you never know where your money to do the next deal might come from. In this article I'll tell you a sto
According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product
ry about how networking with people might turn up your next private investor.
When I first began investing, I figured I would have
When I first began investing, I figured I would have
; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.
Examples of combination products may in
Examples of combination products may in
to go through the traditional lending channels. But I also knew that was very cumbersome. So I wanted to find a source of private f
lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.
nds. One person said if you don’t have your private funding in place, you can miss out on many good deals. Well, I knew I wanted pr
here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe
vate funding, but I didn’t know where to look.
In August 2002, I was doing a foreclosure deal with a double closing. Everyone at t
In August 2002, I was doing a foreclosure deal with a double closing. Everyone at t
d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.
Combination pro
Combination pro
e closing table was dressed very sharply--except for me. For those of you who know me, you know that I can dress pretty dang casua
ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc
in any given circumstance, and when I first started this business I did it all the time. Now, I will dress up somewhat for closin
easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi
s, but a tie is still out of the question.
So I did this deal with all these well-dressed guys there. When we finished the closing
So I did this deal with all these well-dressed guys there. When we finished the closing
nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically
the mortgage lender for the buyers came up and introduced himself to me. I will call him “TB”.
TB said that he had seen the numbe
TB said that he had seen the numbe
and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ
s, and that I had made more money then anyone at that table. My response was my usual: “Well, you win some, and then you win some
ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi
hat are bigger.” And I left it at that.
Well, funny how things happen. I did another deal, and at the closing table sitting across
Well, funny how things happen. I did another deal, and at the closing table sitting across
ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.
Following aspects would a
Following aspects would a
from me was TB. This was a stinky deal. But TB’s professionalism and his ability to work under pressure and get the deal done impr
dd to the challenges in developing combination products:
Which markets to tap where the combination products can do fairly well?
Which combination prod
Which markets to tap where the combination products can do fairly well?
Which combination prod
ssed me. I told him so after the closing. Again, he said that he saw the numbers and he still was pretty impressed. This time, I ha
cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin
a business card and gave it to him.
The next morning, TB called. “I may have a business opportunity for you,” he said. And we sch
The next morning, TB called. “I may have a business opportunity for you,” he said. And we sch
tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen
What would be the developing cost?
How to tackle the risks encountered during combination product developmen
duled a time to get together.
At lunch, TB asked if I ever needed money. He saw how much creativity and enthusiasm I had for the
At lunch, TB asked if I ever needed money. He saw how much creativity and enthusiasm I had for the
t?
As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
eals I was doing. He also was impressed by the fact that I always seemed prepared. He offered to fund deals, up to 90% LTV. That
ping new procedures for reviewing their safety, efficacy and quality.
Professional from academic institutions, pharmaceutical industries, health care indust
Professional from academic institutions, pharmaceutical industries, health care indust
was the difference between him and “hard money” lenders.
I thought to myself, BINGO!! I had been looking for money, but didn't kn
I thought to myself, BINGO!! I had been looking for money, but didn't kn
y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products
w where to get it. Now, I had an investor. TB’s money was expensive--12% interest and 50% of profits--a very, very steep price! How
.
As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
ver, at that time I needed the money to do my real estate deals, and TB became a source of my funds.
These days I use 12% money on
These days I use 12% money on
elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.
Companies that provide selfless information through particip
Companies that provide selfless information through particip
a regular basis and this works just fine for me now.
The lesson of this article: never be surprised where your funds can come from
The lesson of this article: never be surprised where your funds can come from
tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
<a href="http://www.topadding.org.ua/article/139007/topadding-Foreclosure-Investing-Money-Can-Come-From-Anywhere.html">Foreclosure Investing Money Can Come From Anywhere</a>
BB link (for phorums):
[url=http://www.topadding.org.ua/article/139007/topadding-Foreclosure-Investing-Money-Can-Come-From-Anywhere.html]Foreclosure Investing Money Can Come From Anywhere[/url]
Related Articles:
Increase Sum in Your Check Account with Follow-Ups
Bookmark it:
|